I forgot the total amount for each milestone, but we owe a chunk of cash for each milestone closer to FDA approval to who BOT bought SB from. And then there is the cost to actually get this to market, for example marketing, setting up production etc (no pro in this sense either, but I think you’d find it would be quite costly), I honestly wouldn’t be surprised if all of that cash wouldn’t be wound up on SB
I forgot the total amount for each milestone, but we owe a chunk...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.020(6.25%) |
Mkt cap ! $617.9M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 34.3¢ | 32.5¢ | $1.814M | 5.424M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 489055 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 340303 | 4 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |